Skip to content
Disclosery

13F-HR filed by Finepoint Capital LP

Finepoint Capital LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-12, with 38 holding rows worth $261,802,896.

Accession
0000904454-23-000311
Filer
CIK 1608126
Filed
2023-05-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 38 entries on the cover page, a total value of $261,802,896 stated on the cover page (in dollars after the unit check, H1), rows summing to $261,802,896 with VALUE read as dollars as filed, 13F file number 028-16580. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TRAVERE THERAPEUTICS INC89422G107COM875,221$19,683,720dollars as filed
APELLIS PHARMACEUTICALS INC03753U106COM283,690$18,712,192dollars as filed
IVERIC BIO INC46583P102COM723,600$17,605,188dollars as filed
ACADIA PHARMACEUTICALS INC004225108COM916,353$17,245,763dollars as filed
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR444,659$17,181,624dollars as filed
SAREPTA THERAPEUTICS INC803607100COM122,757$16,919,597dollars as filed
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR156,072$16,734,040dollars as filed
SAGE THERAPEUTICS INC78667J108COM388,865$16,316,775dollars as filed
AMICUS THERAPEUTICS INC03152W109COM1,460,175$16,193,341dollars as filed
PROTHENA CORP PLC SHSG72800108Stock331,600$16,072,652dollars as filed
SPRINGWORKS THERAPEUTICS INC85205L107COM614,231$15,810,306dollars as filed
CYTOKINETICS INC23282W605COM NEW413,793$14,561,376dollars as filed
CRINETICS PHARMACEUTICALS INC COM22663K107Stock868,427$13,946,938dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock846,270$13,938,067dollars as filed
ARVINAS INC04335A105COM492,300$13,449,636dollars as filed
CEREVEL THERAPEUTICS HLDNG I15678U128COM539,445$13,157,064dollars as filed
SOLID BIOSCIENCES INC83422E204COMMON STOCK488,857$2,317,182dollars as filed
ARES ACQUISITION CORPORATIONG33032122*W EXP 02/02/202504,706$444,141dollars as filed
HOME PLATE ACQUISITION CORP43734R111*W EXP 09/30/202690,000$218,730dollars as filed
BRIDGETOWN HOLDINGS LTDG1355U121*W EXP 09/30/202895,000$134,429dollars as filed
ROSS ACQUISITION II CORPg7641c114WT439,666$115,192dollars as filed
CONYERS PARK III ACQSITN COR21289P110*W EXP 08/12/202571,666$114,333dollars as filed
CHURCHILL CAPITAL CORP V17144T115*W EXP 10/29/202612,000$114,322dollars as filed
MARBLEGATE ACQUISITION CORP56608A113*W EXP 08/31/202735,000$110,177dollars as filed
SUMMIT HEALTHCARE ACQUISITIONg9845f117WT489,999$76,293dollars as filed
CHURCHILL CAPITAL CORP VII17144M110*W EXP 02/29/202548,000$67,130dollars as filed
AFTERNEXT HEALTHTECH ACQUISIG01109126*W EXP 99/99/999366,666$61,087dollars as filed
ZIMMER ENERGY TRANSITION ACQ989570114*W EXP 06/16/202358,270$60,118dollars as filed
JAWS HURRICANE ACQUISITN COR47201B111*W EXP 03/26/202387,249$60,062dollars as filed
SWIFTMERGE ACQUISITION CORPG63836111*W EXP 12/13/202490,000$59,878dollars as filed
COMPASS DIGITAL ACQUISITION COg2476c123WT459,906$59,834dollars as filed
CHURCHILL CAPITAL CORP VI17143W119*W EXP 02/17/202540,000$59,400dollars as filed
CORSAIR PARTNERING CORPG2540H116*W EXP 07/06/202334,666$53,580dollars as filed
SENIOR CONNECT ACQUISITN COR81723H116*W EXP 12/31/2021,014,000$51,308dollars as filed
CONCORD ACQUISITION II CORP20607u116WT408,333$28,583dollars as filed
CALIDI BIOTHERAPEUTICS INC320703119*W EXP 03/14/202655,200$26,863dollars as filed
BILANDER ACQUISITION CORP09001T114*W EXP 05/19/202183,749$23,887dollars as filed
SKYDECK ACQUISITION CORPG82220115*W EXP 05/13/202361,756$18,088dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000904454-23-000311this filing2023-05-12acceptance time not in the bulk data set